Disease & Country disbursements amounts in USD
Global Fund Allocations 2014 - 2016 $14 B
Global Fund Donors

GFO Live

In West and Central Africa, countries which for the most part are low-income and facing high burdens of disease, there are gaps in diagnosis and testing, as well as treatment, that are taxing already overburdened health systems. To respond to these challenges is the need for reinvigorated efforts...
29 Jan 2015

The town of Kakanj, just north of the capital Sarajevo, is home to Roma settlements of homes like this one, cobbled together from scavenged materials. A resettlement plan was initiated by the Bosnia and Herzegovinan government in 2009 but has not been able to keep up with demand. There are...
29 Jan 2015
With the end of eligibility for Bosnia and Herzegovina for Global Fund support, World Vision is drawing-down its long-running outreach program that worked to promote a better understanding of TB and HIV among the country's marginalized Roma populations.
From humble beginnings in 1999, the program...
28 Jan 2015
Eleven Pacific Island countries have endorsed a multi-country concept note to respond to the varying HIV epidemics among their respective populations, ahead of submission expected on 30 January. The concept note -- among the only multi-country notes to be developed under the new funding model --...
28 Jan 2015
I am writing on behalf of Kimirina Corporation, the civil society principal recipient named in the recent OIG audit of Ecuador (see article here).
Kimirina has worked with the Global Fund since 2009, on a Round 9 HIV grant seeking to help lift barriers to access to services for all people in...
28 Jan 2015

Aidspan is an international non-profit organization based in Kenya whose mission is to reinforce the effectiveness of the Global Fund to Fight AIDS, Tuberculosis and Malaria by serving as an independent watchdog of the Fund and its grant implementers

Examining the trends in costs of medicines for drug-susceptible and drug-resistant tuberculosis from 2010 - 2013; an analysis of Global Fund PQR data
15 Jan 2015

The paper examines the trends in costs of medicines to treat drug susceptible and drug-resistent tuberculosis. The trends include a comparison between the High Burden Countries, as categorized by WHO, and the other countries that all receive or have received Global Fund support.